Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, January 30, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Vincent Andrews Initiated (CC) at Hold and Held Target at $58 on, Jan 30th, 2018
Vincent Andrews of Morgan Stanley, Initiated "The Chemours Company" (CC) at Hold and Held Target at $58 on, Jan 30th, 2018.
Vincent has made no other calls on CC in the last 4 months.
There are 3 other peers that have a rating on CC. Out of the 3 peers that are also analyzing CC, 2 agree with Vincent's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Robert Koort of "Goldman Sachs" Downgraded from Strong Buy to Hold on, Wednesday, December 6th, 2017
- John Roberts of "UBS" Maintained at Hold with Increased Target to $59 on, Friday, November 3rd, 2017
This is the rating of the analyst that currently disagrees with Vincent
- Duffy Fischer of "Barclays" Maintained at Buy with Increased Target to $58 on, Monday, November 6th, 2017
